Retroperitoneal Inflammation Detected on FDG PET/CT in Patient on Long-Term Immunotherapy

Article Radiology, Nuclear Medicine & Medical Imaging

18F-FDG PET/CT features of immune-related adverse events and pitfalls following immunotherapy

Martin H. Cherk et al.

Summary: This article reviews the appearances of frequently encountered immune-related adverse events (irAEs) on F-18-FDG PET/CT in clinical practice, along with a brief discussion on pseudoprogression and hyperprogression.

JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2022)

添加到收藏夹

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

18F-FDG PET/CT Imaging of Immune Checkpoint Inhibitor-Related Retroperitoneal Panniculitis

Fabio Minutoli et al.

CLINICAL NUCLEAR MEDICINE (2022)

添加到收藏夹

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Nivolumab Immunotherapy-Related Skin Reactions Detected on 18F-FDG PET/CT in Renal Cell Cancer

T. Thayumanavan et al.

Summary: Nivolumab is a new therapy option for metastatic cancers, but it may cause immune-related adverse events, especially cutaneous toxicities. These adverse events may lead to misleading results on PET/CT scans, so caution is required during interpretation.

CLINICAL NUCLEAR MEDICINE (2022)

添加到收藏夹

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Pembrolizumab-Induced Thyroiditis and Colitis-Presentation and Resolution on Serial FDG PET/CT

Ayah Adel Nawwar et al.

Summary: A 58-year-old man with previous melanoma underwent PET/CT prior to starting pembrolizumab. After 3 months of treatment, PET/CT showed partial metabolic response and signs of thyroiditis and colitis. Stopping pembrolizumab led to resolution of the inflammatory changes.

CLINICAL NUCLEAR MEDICINE (2021)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

Immunotherapy-Related Imaging Findings in Patients with Gynecological Malignancies: What Radiologists Need to Know

Luca Russo et al.

Summary: Immunotherapy plays a crucial role in the treatment of gynecological malignancies, and radiologists should be familiar with immune-related imaging features for tumor evaluation. This paper briefly presents immune checkpoint inhibitors and their mechanisms of action for gynecological malignancies, as well as discussing patterns of pseudoprogression and different forms of immune-related adverse events.

KOREAN JOURNAL OF RADIOLOGY (2021)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging